Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/25 16:11 | 6/13/25 | CTMX | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | 4 | S.dm | -47 | 1.83 | 0 | -26 | 226 | D | |||||||||||||||
6/17/25 16:10 | 6/16/25 | CTMX | Health | Drug | Pharmaceutical Preparations | Belvin Marcia | CA | O | SVP,Chie | 4 | S.d | -81 | 1.61 | 0 | -50 | 272 | D | |||||||||||||||
6/17/25 16:09 | 6/16/25 | CTMX | Health | Drug | Pharmaceutical Preparations | McCarthy Sean A. | CA | DO | CEO | 4 | S.d | -231 | 1.82 | 0 | -127 | 1,183 | D | |||||||||||||||
3/20/25 16:32 | 3/18/25 | CTMX | Health | Drug | Pharmaceutical Preparations | Chu Yu-Waye | CA | O | Chief Me | 1 | S | -2 | 0.5990 | 0 | -4 | 136 | D | |||||||||||||||
3/20/25 16:32 | 3/18/25 | CTMX | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | 3 | S.d | -22 | 1.13 | 0 | -20 | 131 | D | |||||||||||||||
8/22/24 18:01 | 8/20/24 | CTMX | Health | Drug | Pharmaceutical Preparations | Landau Jeffrey B | CA | O | Chief Bu | 2 | S.d | -19 | 1.75 | 0 | -11 | 127 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |